Tower Trust & Investment CO Biogen Inc. Transaction History
Tower Trust & Investment CO
- $124 Billion
- Q1 2025
A detailed history of Tower Trust & Investment CO transactions in Biogen Inc. stock. As of the latest transaction made, Tower Trust & Investment CO holds 2,727 shares of BIIB stock, worth $339,238. This represents 0.27% of its overall portfolio holdings.
Number of Shares
2,727Holding current value
$339,238% of portfolio
0.27%Shares
1 transactions
Others Institutions Holding BIIB
# of Institutions
1,015Shares Held
125MCall Options Held
1.64MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17MShares$2.12 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.9MShares$1.98 Billion1.84% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.81 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$920 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA4.67MShares$581 Million0.13% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $17.9B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...